Blood Pressure Monitoring Devices - Market Insights, Competitive Landscape, and Market Forecast - 2034

Blood Pressure Monitoring Devices Market Summary

Overview:

• The Blood Pressure Monitoring Devices market is estimated at USD 4.20 billion in 2025 and is projected to reach USD 9.60 billion by 2034. Growth is anchored in the rising global burden of hypertension and cardiovascular disease, accelerating adoption of home-based and self-monitoring devices, and growing integration of digital, connected, and AI-enabled health technologies.
• The global Blood Pressure Monitoring Devices market is growing at a CAGR of 9.6% during the forecast period from 2026 to 2034.
• By product, the Digital/Automated Blood Pressure Monitors segment dominated the Blood Pressure Monitoring Devices market with a 64% share in 2025.
• By end-user, the Home-Care Settings segment dominated the Blood Pressure Monitoring Devices market with a 58% share in 2025.
• North America dominated the global Blood Pressure Monitoring Devices market revenue with a 39% share in 2025, representing the highest regional market share globally.

A blood pressure monitoring device is a diagnostic instrument used to measure systolic and diastolic arterial pressure in clinical, ambulatory, and home-care settings for the screening, diagnosis, and ongoing management of hypertension and cardiovascular disease. The market spans digital/automated blood pressure monitors, including wearable, upper arm-based, wrist-based, and finger-based devices that use oscillometric and increasingly cuffless sensing technologies, and manual blood pressure monitors, including mercury and aneroid sphygmomanometers that remain widely used for their low cost and auscultatory accuracy. Devices are deployed across hospitals, ambulatory surgical centers, home-care settings, and other care environments, with adoption accelerating as connected, Bluetooth- and Wi-Fi-enabled monitors integrate with mobile health applications, electronic health records, and remote patient monitoring platforms. Driven by the rising global prevalence of hypertension, an aging population, growing consumer health awareness, and continuous innovation in cuffless, AI-enabled, and atrial-fibrillation-detecting technologies, blood pressure monitoring devices have become essential tools underpinning both clinical cardiovascular care and the expanding home healthcare and digital health ecosystem.

Blood Pressure Monitoring Devices Market Key Growth Drivers

• The rising global burden of hypertension is a foundational driver, with public health data indicating that more than 1.13 billion adults worldwide live with hypertension and that the condition contributes to over 7.6 million deaths annually, sustaining structural demand for screening and monitoring devices.
• Growing consumer preference for home-based and self-monitoring is expanding demand for digital upper-arm, wrist, and wearable monitors, as patients seek to track hypertension conveniently outside clinical settings and share readings with physicians remotely.
• Rapid technological advancement, including Bluetooth and Wi-Fi connectivity, cuffless and optical sensing, and AI-enabled atrial fibrillation detection, is broadening the functionality and clinical value of connected blood pressure monitors.
• The rising geriatric population and increasing prevalence of obesity, diabetes, and sedentary lifestyles are elevating cardiovascular risk and expanding the patient pool requiring routine blood pressure monitoring.
• Expansion of telehealth and remote patient monitoring ecosystems is increasing integration of connected blood pressure devices with mobile health apps, electronic health record systems, and virtual-care platforms.
• Stringent accuracy and validation standards, including ISO 81060-2:2018+A1:2020 and protocols recognized by the European Society of Hypertension and the American Heart Association, are pushing manufacturers toward clinically validated, higher-accuracy devices.
• Strategic investment, product launches, and M&A activity among leading manufacturers, including Philips' completed acquisition of EarlySense in December 2025 and its renewed multi-year patient-monitoring partnership with Masimo in September 2025, are strengthening connected monitoring portfolios.
• The convergence of rising hypertension prevalence, home healthcare adoption, and digital health integration is expected to sustain steady double-digit-adjacent growth in the market through 2034.

Key Companies in Blood Pressure Monitoring Devices Market

The competitive landscape is led by the following active device manufacturers:

• Koninklijke Philips N.V.
• General Electric Company
• A&D Company, Limited
• Hill-Rom Services, Inc.
• American Diagnostic Corporation
• Withings
• Spacelabs Healthcare
• Braun Healthcare
• GF Health Products, Inc.
• Microlife Corporation

Factors Contributing to the Growth of the Blood Pressure Monitoring Devices Market

Market Drivers

Rising Global Burden of Hypertension and Cardiovascular Disease

The single most powerful driver of the Blood Pressure Monitoring Devices market is the sheer scale of the global hypertension burden. Public health surveillance indicates that more than 1.13 billion adults worldwide live with hypertension, and the condition is linked to over 7.6 million deaths annually, making it the leading modifiable risk factor for cardiovascular disease, stroke, and kidney failure. Despite this scale, awareness and treatment rates remain suboptimal in many regions, prompting public-health campaigns such as May Measurement Month to expand screening access. As cardiovascular disease incidence continues to rise alongside aging populations and lifestyle-related risk factors, demand for accurate, accessible blood pressure monitoring devices across hospitals, clinics, and homes continues to expand, anchoring market growth through 2034.

Growing Preference for Home-Based and Self-Monitoring

A structural shift toward home-based blood pressure management is a central growth engine for the market. Patients and physicians increasingly favor self-monitoring because it reduces healthcare costs, captures more representative readings than sporadic clinic visits, and helps identify white-coat and masked hypertension. This shift has driven strong demand for compact, easy-to-use digital upper-arm, wrist, and wearable monitors, exemplified by product launches such as Withings' BPM Vision, a travel-size, Wi-Fi-enabled home monitor with a large color display that received FDA clearance in the United States in April 2025 and launched in the European Union in October 2025 with added atrial fibrillation detection and on-device ECG. As home healthcare infrastructure matures and consumer familiarity with connected monitoring grows, this trend is expected to sustain the leadership of home-care settings across the forecast period.

Market Restraints

Despite strong momentum, the Blood Pressure Monitoring Devices market faces material constraints. Intense price competition among a large number of manufacturers, ranging from multinational medical technology companies to specialized regional producers, exerts continuous downward pressure on margins, particularly in the manual and entry-level digital device segments. Measurement accuracy concerns persist, as inconsistent cuff sizing, improper technique, and device calibration drift can compromise reading reliability, particularly for lower-cost consumer devices that lack rigorous clinical validation. The gradual phase-out of mercury-based sphygmomanometers, driven by environmental and safety regulations such as the Minamata Convention on Mercury, is disrupting a historically reliable and cost-effective product category and requiring manufacturers and healthcare systems to transition to aneroid and digital alternatives. Reimbursement for home blood pressure monitors and connected devices remains inconsistent across geographies, limiting adoption in price-sensitive and lower-income markets. Data privacy and cybersecurity concerns associated with connected, cloud-synced monitoring devices add compliance complexity for manufacturers, while limited digital literacy and connectivity infrastructure in emerging markets constrain adoption of smart and app-connected monitors. Together, these pricing, accuracy, regulatory, reimbursement, and infrastructure barriers temper the pace of growth, even as the underlying drivers of hypertension prevalence, home healthcare adoption, and digital health integration remain firmly intact.

Blood Pressure Monitoring Devices Market Segment Analysis

The Blood Pressure Monitoring Devices Market by Product (Digital/Automated Blood Pressure Monitors {Wearable Blood Pressure Monitors, Upper Arm-based Blood Pressure Monitors, Wrist-based Blood Pressure Monitors, and Finger-based Blood Pressure Monitors} and Manual Blood Pressure Monitors {Mercury Blood Pressure Monitors and Aneroid Blood Pressure Monitors}), End-User (Hospitals, Ambulatory Surgical Centers, Home-Care Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of World).

By Product

Dominant Subsegment: Digital/Automated Blood Pressure Monitors. The Digital/Automated Blood Pressure Monitors category is expected to dominate the market.

Dominant: Digital/Automated Blood Pressure Monitors ~ 64%

The Digital/Automated Blood Pressure Monitors segment accounted for 64% of the Blood Pressure Monitoring Devices market in 2025. Digital and automated monitors, spanning wearable, upper arm-based, wrist-based, and finger-based devices, are the leading product category because they offer user-friendly, one-button operation, automated oscillometric measurement, and increasing integration with mobile health applications, making them the preferred choice across both clinical and home-care environments. Upper arm-based digital monitors remain the clinical gold standard for accuracy and are widely recommended by cardiology societies, while wrist-based and finger-based devices are gaining traction for portability and convenience despite generally lower clinical accuracy. Wearable blood pressure monitors, including cuffless and continuous monitoring form factors, represent the fastest-growing product niche as manufacturers pursue optical and sensor-based technologies that reduce reliance on inflatable cuffs. Manual mercury and aneroid blood pressure monitors continue to hold a meaningful share in cost-sensitive and resource-limited settings, valued for their low cost, durability, and lack of dependence on batteries or connectivity, and aneroid devices in particular are gaining share as regulatory phase-outs of mercury-based devices continue. Nonetheless, the accuracy, convenience, and expanding connectivity features of digital and automated monitors secure the segment's clear leadership across the forecast period.

By End-User

Dominant Subsegment: Home-Care Settings. The home-care settings category is expected to dominate the market.

Dominant: Home-Care Settings ~ 58%

The Home-Care Settings segment accounted for 58% of the Blood Pressure Monitoring Devices market in 2025. Home-care settings lead the market because rising awareness of hypertension, growing preference for self-monitoring, and the increasing affordability and connectivity of digital blood pressure monitors have made at-home measurement the most common mode of routine blood pressure tracking. Patients managing chronic hypertension increasingly rely on validated home devices to track readings between clinical visits, share data with physicians, and detect conditions such as white-coat and masked hypertension that clinic-only measurement can miss. Hospitals remain a significant end-user, relying on both manual and automated devices for admission screening, continuous ward monitoring, and ambulatory blood pressure monitoring for diagnostic confirmation, and this segment continues to grow steadily as hospital infrastructure expands, particularly in emerging markets. Ambulatory surgical centers represent a smaller but growing end-user category, driven by the rising volume of outpatient procedures requiring perioperative blood pressure monitoring. While hospitals are expected to grow at a healthy pace given rising procedure volumes and continuous monitoring needs, the sheer scale and accelerating adoption of self-monitoring at home secure the home-care settings segment's clear leadership across the forecast period.

Blood Pressure Monitoring Devices Market Region Analysis

Dominant Region: North America

North America accounted for 39% of the global Blood Pressure Monitoring Devices market revenue in 2025, representing the highest regional market share globally. The region's dominance reflects a well-established healthcare infrastructure, high prevalence of hypertension, strong reimbursement frameworks, and rapid adoption of connected and digital monitoring devices, particularly in the United States. North America hosts a dense concentration of leading manufacturers and a mature retail and clinical distribution network, and sponsors benefit from proximity to innovation hubs driving continuous product launches, such as Withings' BPM Vision and American Diagnostic Corporation's expanding Advantage monitor line. The region's aging population, high rates of obesity and cardiovascular disease, and strong consumer awareness of home health monitoring, combined with active regulatory clearance activity from the FDA, sustain substantial demand across hospital, ambulatory, and home-care channels. Continued investment in telehealth integration and connected health platforms anchors the region's continued leadership across the forecast period.

Dominant: North America ~ 39% (Largest)

Fastest Growing Region: Asia-Pacific

Asia-Pacific is the fastest-growing region in the Blood Pressure Monitoring Devices market. The region's elevated CAGR is driven by rising hypertension and cardiovascular disease incidence, rapid expansion of healthcare infrastructure, and growing healthcare investment across China, Japan, India, South Korea, and Australia. China is expanding hospital and primary-care screening infrastructure, Japan is advancing connected and wearable monitoring technologies, and India is emerging as both a large patient population and a growing manufacturing base offering cost-competitive digital devices. Government-led hypertension screening programs, expanding health insurance coverage, and rising consumer adoption of home health monitoring devices are accelerating uptake across the region, while local and multinational manufacturers scale distribution networks to reach underserved rural and semi-urban populations. The combination of high disease burden, expanding infrastructure, and rising consumer health awareness positions Asia-Pacific as the principal source of incremental growth over the forecast period.

Regional Commentary

North America

North America accounted for 39% of the global Blood Pressure Monitoring Devices market revenue in 2025. The United States dominates on the strength of its healthcare infrastructure, high hypertension prevalence, strong reimbursement environment, and rapid adoption of connected monitoring devices, while continued product innovation from leading manufacturers and expanding telehealth integration reinforce the region's leadership.

Europe

Europe is a large and advanced regional market, supported by established regulatory frameworks under CE marking, strong clinical validation standards set by the European Society of Hypertension, and a mature base of manufacturers including Koninklijke Philips N.V., Withings, and Braun Healthcare. Product launches such as Withings' European rollout of BPM Vision with AFib detection reinforce the region's role in advancing connected home monitoring across Germany, France, the United Kingdom, Italy, and Spain.

Asia-Pacific

Asia-Pacific is the fastest-growing region, propelled by rising hypertension and cardiovascular disease incidence, rapid healthcare infrastructure build-out, and growing healthcare investment across China, Japan, India, South Korea, and Australia. Expanding government screening initiatives, rising insurance coverage, and growing consumer adoption of home health monitoring devices are accelerating regional market growth.

Rest of World

The Rest of the World region, spanning Latin America, the Middle East, and Africa, is an emerging growth frontier. Expanding healthcare infrastructure, rising hypertension awareness and screening initiatives, and efforts to broaden access to affordable manual and digital monitoring devices are gradually increasing adoption, while international partnerships and public health campaigns support the build-out of regional distribution and screening capacity.

Blood Pressure Monitoring Devices Market Competitive Landscape

The Blood Pressure Monitoring Devices market is classified as Highly Competitive and Fragmented. A group of large, diversified medical technology players with global distribution and broad connected-health portfolios, including Koninklijke Philips N.V., General Electric Company, and Hill-Rom Services, Inc., anchor the upper tier of the market, while specialized and fast-scaling manufacturers such as A&D Company, American Diagnostic Corporation, Withings, Spacelabs Healthcare, Braun Healthcare, GF Health Products, Inc., and Microlife Corporation compete through product innovation, clinical validation, price competitiveness, and deep channel relationships across hospital, retail, and home-care distribution, sustaining intense competition across both digital and manual device categories.

The competitive landscape can be evaluated across the following dimensions:

• Market concentration: Highly competitive and fragmented, with diversified global medtech players leading alongside a large field of specialized digital-health and traditional device manufacturers.
• Leading players: Koninklijke Philips N.V., General Electric Company, and Hill-Rom Services, Inc. anchor the top tier through diversified patient-monitoring portfolios and global distribution networks.
• Geographic reach: Leading manufacturers operate global distribution networks spanning hospital, retail, and e-commerce channels across developed and emerging markets.
• Product portfolio strength: Top players offer end-to-end portfolios spanning manual sphygmomanometers, digital upper arm and wrist monitors, ambulatory blood pressure monitoring systems, and connected wearable devices.
• Technology and connectivity: Bluetooth and Wi-Fi connectivity, mobile app integration, AI-enabled AFib detection, and cuffless sensing are increasingly decisive competitive differentiators.
• Strategic partnerships: Tie-ups spanning digital health platforms, electronic health record systems, and remote patient monitoring providers, such as Philips' collaborations with Epic Systems and Masimo, extend reach and clinical integration.
• M&A activity: Active consolidation, including Philips' completed acquisition of EarlySense in December 2025, is expanding connected home-monitoring portfolios among leading manufacturers.
• Manufacturing and validation capabilities: Clinically validated accuracy, ISO 81060-2 compliance, and proprietary cuff and sensing technologies are key competitive moats.
• Innovation focus: Cuffless and optical sensing, AI-enabled AFib detection, connected home monitoring ecosystems, and continued redesign of traditional manual devices for improved ergonomics and durability.

Blood Pressure Monitoring Devices Market Recent Developmental Activities

In December 2025, Koninklijke Philips N.V. completed its acquisition of EarlySense, a health-monitoring technology firm, expanding its home-based vital-sign monitoring portfolio, including blood pressure tracking capabilities. Strategic significance: Strengthens Philips' connected home health monitoring portfolio and broadens its vital-signs technology base.

In September 2025, Koninklijke Philips N.V. renewed a multi-year strategic collaboration with Masimo to integrate patient-monitoring technologies, including plans to accelerate development of AI-driven clinical algorithms through 2026 and beyond. Strategic significance: Reinforces Philips' multiparameter patient-monitoring leadership and extends its clinical technology partnerships.

Blood Pressure Monitoring Devices Market Segmentation

Blood Pressure Monitoring Devices Market by Product

• Digital/Automated Blood Pressure Monitors
• Wearable Blood Pressure Monitors
• Upper Arm-based Blood Pressure Monitors
• Wrist-based Blood Pressure Monitors
• Finger-based Blood Pressure Monitors
• Manual Blood Pressure Monitors
• Mercury Blood Pressure Monitors
• Aneroid Blood Pressure Monitors

Blood Pressure Monitoring Devices Market by End-Users

• Hospitals
• Ambulatory Surgical Centers
• Home-Care Settings
• Others

Blood Pressure Monitoring Devices Market by Geography

• North America Blood Pressure Monitoring Devices Market
• United States Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
• Canada Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
• Mexico Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
• Europe Blood Pressure Monitoring Devices Market
• Germany Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
• United Kingdom Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
• France Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
• Italy Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
• Spain Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
• Rest of Europe Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
• Asia-Pacific Blood Pressure Monitoring Devices Market
• China Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
• Japan Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
• India Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
• Australia Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
• South Korea Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
• Rest of Asia-Pacific Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
• Rest of the World (RoW) Blood Pressure Monitoring Devices Market
• Middle East Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
• Africa Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)
• South America Blood Pressure Monitoring Devices Market Size in USD million (2023-2034)

Key Takeaways from the Blood Pressure Monitoring Devices Market Report Study

• Market size analysis for the current blood pressure monitoring devices market size (2025), and market forecast for 9 years (2026 to 2034).
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures that happened over the last 3 years.
• Key companies dominating the global blood pressure monitoring devices market.
• Various opportunities available for competitors in the blood pressure monitoring devices market space.
• What are the top-performing segments in 2025? How will these segments perform in 2034?
• Which are the top-performing regions and countries in the current blood pressure monitoring devices market scenario?
• Which are the regions and countries where companies should concentrate their opportunities for blood pressure monitoring devices market growth in the future?

Target audience who can benefit from this Blood Pressure Monitoring Devices market report study

• Blood pressure monitoring devices product providers
• Research organizations and consulting companies
• Blood pressure monitoring devices-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in blood pressure monitoring devices
• Various end-users who want to know more about the blood pressure monitoring devices market and the latest technological developments in the blood pressure monitoring devices market.

Frequently Asked Questions:

Q1. What is the growth rate of the blood pressure monitoring devices market?

The blood pressure monitoring devices market is projected to expand at a CAGR of 9.6% during the forecast period from 2026-2034.

Q2. What is the market size of the blood pressure monitoring devices market?

The blood pressure monitoring devices market is estimated at USD 4.20 billion in 2025 and is projected to reach USD 9.60 billion by 2034.

Q3. Which region dominates the blood pressure monitoring devices market?

North America dominated the Blood Pressure Monitoring Devices market with a 39% share of global revenue in 2025, supported by well-established healthcare infrastructure, high hypertension prevalence, strong reimbursement frameworks, and rapid adoption of connected monitoring devices. Asia-Pacific is the fastest-growing region over the forecast period.

Q4. What are the key drivers of the blood pressure monitoring devices market?

The principal drivers are the rising global burden of hypertension, which affects more than 1.13 billion adults worldwide and contributes to over 7.6 million deaths annually; growing consumer preference for home-based and self-monitoring; rapid technological advancement in digital and connected devices; the rising geriatric population and chronic disease prevalence; and expanding telehealth and remote patient monitoring ecosystems.

Q5. Who are the major players in the blood pressure monitoring devices market?

The major players include Koninklijke Philips N.V., General Electric Company, A&D Company, Limited, Hill-Rom Services, Inc., American Diagnostic Corporation, Withings, Spacelabs Healthcare, Braun Healthcare, GF Health Products, Inc., and Microlife Corporation, among other active manufacturers profiled in the Competitive Landscape section.